<DOC>
	<DOCNO>NCT01986673</DOCNO>
	<brief_summary>The purpose study evaluate single dose sildenafil cream ( SST-6006 ) absorb eliminate body , without use condom , compare single oral sildenafil dose evaluate safety sildenafil cream .</brief_summary>
	<brief_title>Single-Dose Relative Bioavailability Study SST-6006 , Topical Sildenafil Cream Versus Oral Sildenafil Healthy Male Adults</brief_title>
	<detailed_description />
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Willing able sign date write informed consent form ( ICF ) studyspecific screen procedure perform 2 . Men age 18 55 year , inclusive 3 . Body mass index ( BMI = weight [ kg ] /height [ ] 2 ) 18.0 30.0 kg/m2 , inclusive body weight least 50 kg 4 . Nonsmoker past smoker abstinent 6 month study Day 1 5 . Have high probability compliance completion study , opinion Principal Investigator 6 . Healthy determine investigator base medical history , physical examination , clinical laboratory test , vital sign measurement , normal 12lead ECG 7 . Resting supine systolic blood pressure 90 140 mmHg rest supine diastolic blood pressure 50 90 mmHg 8 . Must able achieve successful erection 1 . Presence history disorder may prevent successful completion study 2 . Presence significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , genitourinary , psychiatric disease , unstable medical condition 3 . Subjects history myocardial infarction , stroke , lifethreatening arrhythmia within 6 month prior study Day 1 , history coronary disease cause angina 4 . Subjects retinitis pigmentosa subject sickle cell anemia related anemia , even feel clinically well time screen . Subjects retinitis pigmentosa identify specifically ask whether condition , visual sign symptom condition ( include question subject whether difficulty see night low light , visual field deficit indicate loss peripheral central vision ) , family history 5 . Subjects anatomical deformation penis angulation , cavernosal fibrosis Peyronie 's disease 6 . History orthostatic hypotension orthostatic hypotension present screen visit , define drop systolic blood pressure great 20 mm Hg drop diastolic blood pressure great 10 mm Hg change position supine stand 7 . A history erectile dysfunction prostatectomy 8 . Any surgical medical condition may interfere absorption , distribution , metabolism , excretion test article 9 . Acute disease state ( eg , nausea , vomit , fever , diarrhea ) within 7 day study Day 1 10 . History drug abuse within 1 year study Day 1 11 . History alcoholism within 1 year study Day 1 , admit alcohol abuse , average consumption 2 standard unit alcohol per day ( standard unit equal 12 ounce beer , 1Â½ ounce 80proof alcohol , 6 ounce wine ) 12 . Use prescription drug within 28 day study Day 1 , overthecounter drug , include herbal supplement ( except occasional use acetaminophen [ Tylenol ] vitamin ) within 14 day study Day 1 . If subject take prescription OTC drug direction health care provider , provider consult medication stop purpose study participation . 13 . Positive serologic finding human immunodeficiency virus antibody ( HIV ) , hepatitis B surface antigen ( HBsAg ) hepatitis C antibody ( HCV ) 14 . Positive finding urine drug screen ( eg , amphetamine , barbiturate , benzodiazepine , cannabinoids , cocaine , methadone , opiates ) alcohol screen 15 . Participation clinical trial within 30 day study Day 1 16 . Consumption caffeinecontaining product ( eg , coffee , tea , chocolate , soda ) alcoholic beverage within 48 hour study Day 1 17 . Consumption grapefruit grapefruitcontaining product within 72 hour study Day 1 18 . Any skin break , irritation , lesion present area cream apply , assess screen checkin 19 . A drug food allergy opinion Investigator contraindicate participation study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pharmacokinetic Characterization</keyword>
</DOC>